Journal Home
Search for

Volume 6, Issue 8, Pages 3092-3100 (August 2010)


View previous. 27 of 57 View next.

Mesoporous silica nanotubes coated with multilayered polyelectrolytes for pH-controlled drug release

Yun-Jie Yangab, Xia TaoaCorresponding Author Informationemail address, Qian Houa, Yi Maab, Xuan-Li Chenab, Jian-Feng ChenbCorresponding Author Informationemail address

Received 21 September 2009; received in revised form 10 February 2010; accepted 24 February 2010. published online 02 March 2010.

Abstract 

Two kinds of inorganic/organic hybrid composites based on mesoporous silica nanotubes (MSNTs) and pH-responsive polyelectrolytes have been developed as pH-controlled drug delivery systems via the layer by layer self-assembly technique. One system was based on alternatively loading poly(allylamine hydrochloride) and sodium poly(styrene sulfonate) onto as-prepared MSNTs to load and release the positively charged drug doxorubicin. The other system was synthesized by alternately coating sodium alginate and chitosan onto amine-functionalized MSNTs, which were used as vehicles for the loading and release of the negatively charged model drug sodium fluorescein. Controlled release of the drug molecules from these delivery systems was achieved by changing the pH value of the release medium. The results of in vitro cell cytotoxicity assays indicated that the cell killing efficacy of the loaded doxorubicin against human fibrosarcoma (HT-1080) and human breast adenocarcinoma (MCF-7) cells was pH dependent. Thus, these hybrid composites could be potentially applicable as pH-controlled drug delivery systems.

a Key Lab for Nanomaterials of the Ministry of Education, Beijing University of Chemical Technology, Bei San Huan Dong Road 15, Beijing 100029, People’s Republic of China

b Research Center of the Ministry of Education for High Gravity Engineering and Technology, Beijing University of Chemical Technology, Beijing 100029, People’s Republic of China

Corresponding Author InformationCorresponding authors. Tel.: +86 10 6445 6466; fax: +86 10 6443 4784.

PII: S1742-7061(10)00116-9

doi:10.1016/j.actbio.2010.02.042


View previous. 27 of 57 View next.